Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Impaired driving ability? 127 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 127 reports of Impaired driving ability have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.3% of all adverse event reports for CLONAZEPAM.

127
Reports of Impaired driving ability with CLONAZEPAM
0.3%
of all CLONAZEPAM reports
2
Deaths
30
Hospitalizations

How Dangerous Is Impaired driving ability From CLONAZEPAM?

Of the 127 reports, 2 (1.6%) resulted in death, 30 (23.6%) required hospitalization, and 11 (8.7%) were considered life-threatening.

Is Impaired driving ability Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 127 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Impaired driving ability?

OXYCODONE (702) PREGABALIN (440) LEVOTHYROXINE (257) MORPHINE (247) ACETAMINOPHEN\HYDROCODONE (223) FENTANYL (222) ACETAMINOPHEN\OXYCODONE (211) GABAPENTIN (194) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (177) ALPRAZOLAM (155)

Which CLONAZEPAM Alternatives Have Lower Impaired driving ability Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Impaired driving ability Reports All Drugs Causing Impaired driving ability CLONAZEPAM Demographics